Omkar Pharmachem Ltd.
Snapshot View

View in App

Prices View details >>

21.75 ▼0%

18 August 2022, 04:00:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.omkarpharmachem.co.in
Market Cap 21.93 Cr.
Enterprise Value(EV) 22.65 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.17 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 125.34 Trailing Twelve Months Ending 2022-06
Industry PE 31.29 Trailing Twelve Months Ending 2022-06
Book Value / Share 8.82 Trailing Twelve Months Ending 2022-06
Price to Book Value 2.47 Calculated using Price: 21.75
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.01 Cr. 10,084,800 Shares
FaceValue 10
Company Profile
The company is engaged in the manufacturing of pharmaceutical chemicals.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
1 Month
3 Month
+2.11%
6 Month
+1.40%
1 Year
+9.57%
2 Year
+13.58%
5 Year
+146.60%
10 Year
+294.02%

Ratios View Details >>

9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -0.13 0.04 -0.66 -1.27 2.38 -2.77 -4.72 -3.03 2.59
Return on Capital Employed (%) -0.13 0.04 -0.66 -1.27 2.91 -2.55 -4.11 -2.22 0.22
Return on Assets (%) -0.13 0.04 -0.65 -1.22 2.30 -2.72 -4.49 -2.78 2.36

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 9 9 9 9 9 9 9 8 9 9
Non Curr. Liab. 0 0 0 0 0
Curr. Liab. 0 0 0 1 0 0 1 1 1 1
Minority Int.
Equity & Liab. 9 9 9 10 9 9 9 9 9 10
Non Curr. Assets 9 9 9 9 9 9 9 9 9 9
Curr. Assets 0 0 0 0 0 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 9 9 9 10 9 9 9 9 9 10

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 0 0 0 0 1
Other Income 0
Total Income 0 0 0 0 0 1
Total Expenditure 0 0 0 0 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation
Taxation 0 0 0
Exceptional Items 0
PAT 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 0 0

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 -1 0 0 0 0
Cash Fr. Inv. 0 0 0
Cash Fr. Finan. 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
Public 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 21 Sep 2022
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for Resignation of Chief Financial Officer of the Company
Sat, 17 Sep 2022
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for resignation of Chief Financial Officer of the company
Sat, 03 Sep 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Dear Sir/Maam Please find enclosed herewith the copies of Newspaper Advertisement published on 03rd September 2022 regarding the 27thAnnual General Meeting of the Company to be held on Friday 30th September 2022 at 11:30 am at the registered office of the company.

Technical Scans View Details >>

No Scans Found

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 223,330.10 939.60 +1.0%
Divi's Laboratories Ltd. 97,819.86 3,685.30 -0.2%
Cipla Ltd. 90,339.79 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. 72,565.89 4,317.90 -1.0%
Apollo Hospitals Enterprise Ltd. 63,143.03 4,372.55 -0.4%
Torrent Pharmaceuticals Ltd. 52,359.20 1,549.70 +0.2%
Abbott India Ltd. 40,610.60 19,224.10 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 57.42 939.60 +1.0%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,685.30 -0.2%
Cipla Ltd. Consolidated 2022-06 36.30 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.26 4,317.90 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.47 4,372.55 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.37 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-06 50.22 19,224.10 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.46 939.60 +1.0%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,685.30 -0.2%
Cipla Ltd. Consolidated 2022-06 4.20 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.58 4,317.90 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,372.55 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.19 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-06 13.62 19,224.10 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 939.60 +1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,685.30 -0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,317.90 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,372.55 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-03 0.00 19,224.10 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 939.60 +1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,685.30 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,317.90 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,372.55 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-03 29.95 19,224.10 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 939.60 +1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,685.30 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,317.90 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,372.55 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-03 29.95 19,224.10 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 939.60 +1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,685.30 -0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,317.90 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,372.55 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-03 4,919.27 19,224.10 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 939.60 +1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,685.30 -0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,112.35 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,317.90 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,372.55 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-03 798.70 19,224.10 +0.2%

FAQ's On Omkar Pharmachem Ltd.

What is Omkar Pharmachem share price?
Can I buy Omkar Pharmachem shares now?
What is the Market Cap of Omkar Pharmachem?
What are the key metrics to analyse Omkar Pharmachem?
What is the 52 Week High and Low of Omkar Pharmachem?